ABM is a respiratory technology startup that aims to deliver novel therapeutic solutions and target a large chronic respiratory disease patient population in both hospital and home care environments, who are currently underserved.
Aevice Health develops a connected device platform, the AeviceMD, powered by its proprietary smart wearable stethoscope that helps providers to manage patients with asthma & COPD at home and reduce the risk of hospital admissions.
From the most demanding basic research, to predictive screens for drug discovery, to the tailored selection of precision medicines, AIM Biotech's sophisticated microfluidic systems and human tissue models enable and accelerate the development of cutting-edge therapeutics.
Aktivolabs helps life and health insurers, reinsurers, financial institutions and corporations to understand their clients’ health in real-time and drive meaningful engagement at scale with customers about health and longevity.
AMILI is a precision gut microbiome company based in Singapore serving the region. It develops diagnostics tests, predictive algorithms, microbiome-modifying interventions, and also houses Southeast Asia's first and only gut microbiome bank for clinical use and research.
Articares designs, develops and markets clinically-backed robotics and AI solutions for exercise and rehabilitation of ageing population. It combines premium business offering for providing comprehensive support throughout the hospital to home journey.
AWAK is a patient-centric medical technology company that develops automated, lightweight, and portable (wearable) dialysis systems to enhance the lives of people with kidney disease and their caregivers. It provides solutions to deliver better outcomes along with improving their quality of life.
Biorithm is a global women's health start up that aims to enhance quality and access to care for women. Through FeMoM, designed for remote monitoring of maternal and fetal parameters, Biorithm aims to end preventable pregnancy complications and stillbirth.
Cadi provides SmartSense - a suite of digital health solutions that include real time location tracking, contact tracing, hand hygiene monitoring and infant safety. It helps hospitals improve productivity and quality of care. Many hospitals in Singapore and the region have deployed Cadi SmartSense.
Endofotonics is a MedTech company that uses its proprietary Raman Spectroscopy platform technology to help clinicians improve early cancer diagnosis. Its SPECTRA IMDx™ System is the world’s first and only real-time in-vivo molecular diagnosis using Raman Spectroscopy for early gastric cancer diagnosis.
HealthBeats is a subscription-based RPM platform designed to provide simple-to-use and simple-to-deploy solution for patients and providers. Its end-to-end solution includes regulatory approved medical devices, software platform and comprehensive support services that allow peace of mind to users.
HistoIndex® is a MedTech company that specializes in its proprietary integrated stain-free AI digital pathology platform, as well as in the provision of related services, to assist pathologists in diagnosing various diseases. HistoIndex was co-founded by Dr. Gideon Ho, CEO, and Dr. Dean Tai, CSO.
Imagene Labs aims to be the global leading ‘Precision Health’ company focusing on Skin, Nutrition and Fitness. They provide diagnostics, insights and personalized products and services in both direct-to-consumer and business-to-business channels.
One of Asia’s fastest growing medical technology developers and medical laboratory operators, INEX is Asia’s first women’s health technology group. Founded by maternal-fetal clinicians, INEX develops and commercialises molecular diagnostic technologies in the areas of fetal health & women’s oncology.
Kinexcs is an AI-driven digital therapy platform & wearables company enabling and empowering people for mobility and a better quality of life. It utilises advanced IoT wearable tech and AI algorithms to reduce the burden of healthcare providers and patients with musculoskeletal conditions.
KYAN has developed an AI-enabled personalised medicine platform for cancer treatment that utilises proprietary hardware and AI/ ML to optimise the best possible drug/ dose combination, offering it as a clinical decision-making tool for physicians to prescribe treatment.
Ligature Therapeutics (LTx) is an early-stage biotech company generating targeted protein degraders (TPD). LTx is advancing its structure agnostic fragment-based drug discovery platform to generate cancer-selective TPDs, and has achieved early proof of concept with a lead asset.
Mesh Bio is a healthtech startup addressing the global burden of chronic metabolic diseases. Mesh Bio provides clinical decision support predictive analytics and automation solutions for patient management; enabling data driven care delivery and precision patient intervention at scale.
MiyaHealth builds technology that improves every part of the patient journey. Their 3 products, MiyaPayor, MiyaPatient, and MiyaProvider, enable patients to access affordable healthcare, manage their chronic illness, and help payors and providers improve patient experience.
Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapies for the treatment of cardiomyopathies. Nuevocor raised US$24 million in its first funding round which it will use to advance its research and bring its innovative cardiac therapies closer to the clinic.
Pathnova is a digital pathology startup using AI to enable scalable and early detection of nose cancer and systemic autoimmune disease. As a MOH-licensed clinical laboratory, they are currently involved in the largest nose cancer screening study to date in Singapore.
Supported by two strategics with a global footprint, Pedra's perfusion monitor has achieved FDA's Breakthrough Device Designation. Its goal is to be part of every peripheral balloon angioplasty or bypass procedure, as they seek to improve limb salvage in the treatment of peripheral artery disease.
Qritive develops clinical-grade AI-powered solutions to support pathologists in every step of the way, helping them to optimise patient outcomes and enable fast, accurate, and affordable cancer diagnosis.
QuantumTX is a Healthcare company employing its unique Quantum Mitohormesis tech to bring additional benefits of exercise without added stress or strain. It is helping seniors everywhere stay fit and healthy, enhancing top-athletes’ performance, and enabling exercise to be prescribed as medicine.
Riverr connects the world’s health data. The platform solves fragmentation that have held back AI and patient-level data collaboration in the past, giving healthcare organisations the ability to make accurate, explainable, and actionable predictions of individual-level health risks.
Singapore Institute of Advanced Medicine Holdings is a healthcare service provider that uses advanced technology for early and accurate diagnosis, and offers appropriate treatments to achieve better outcomes and quality of life for their patients, including those with cancer, neurodegenerative and cardiovascular diseases.
twoplus develops and commercializes proprietary fertility products that help couples with fertility issues. twoplus is a first mover in providing an ecosystem of home-based fertility solutions that leverage patented technologies to address the varied needs of a couples’ conception journey.
Workforce Optimizer (WFO) is a leading provider of AI-enabled workforce management software solution. Unlike existing approaches, WFO employs award-winning AI algorithms that synthesize and process complex rules to predict labor demand, optimise team schedules, and dynamically re-deploy workforce.
Zenyum stands for delivering excellent Smile Cosmetics products that stand out in a competitive environment and make them proud. They deliver value from a proven technology, cutting-edge design and brand communication.